丁二磺酸腺苷蛋氨酸联合熊去氧胆酸治疗妊娠期肝内胆汁淤积症40例

丁二磺酸腺苷蛋氨酸联合熊去氧胆酸治疗妊娠期肝内胆汁淤积
症40例
朱瑜;黄小萍;谢涵
【期刊名称】《医药导报》
【年(卷),期】2015(34)8
【摘要】目的：观察丁二磺酸腺苷蛋氨酸( SAMe)联合熊去氧胆酸( UDCA)治疗妊娠期肝内胆汁淤积症( ICP)的临床疗效及安全性。

方法将80例ICP患者随机分为
治疗组和对照组各40例。

对照组静脉滴注SAMe 1.0 g,qd,治疗组联合口服UDCA 250 mg,tid。

两组治疗前后分别进行瘙痒评分,检测总胆红素(TB)、血清总
胆汁酸(TBA)、甘胆酸( CG)、天门冬酸氨基转移酶( AST)和丙氨酸氨基转移酶
( ALT)的血清浓度,记录两组终止妊娠孕周、剖宫产率、早产率、胎儿窘迫发生率、羊水粪染率。

结果治疗后两组患者的瘙痒评分均明显降低,治疗组TB、TBA、AST、ALT的含量分别由治疗前的(27.83±9.34),(45.62±18.30)μmol·L-1及
(195.98±30.22),(188.69±29.11) U·L-1降低至治疗后的
(11.81±4.91),(11.88±2.23)μmol·L-1及(73.59±21.53),(67.94±30.53) U·L-1,对
照组TB、TBA、AST、ALT的含量分别由治疗前的
(27.49±7.87),(49.12±10.39)μmol·L-1及(211.93±34.97),(210.40±43.39) U·L-1降低至治疗后的(16.08±6.23),(23.88±6.63)μmol·L-1及
(87.20±32.52),(81.77±35.16) U·L-1(P<0.05)。

治疗组肝功能改善程度、新生儿
早产率、胎儿窘迫率、剖宫产率与对照组比较均差异无统计学意义(P>0.05),但治
疗组在TB、TBA、CG降低方面优于对照组(P<0.05)。

结论单用SAMe在瘙痒症状、肝功能指标改善、妊娠结局方面可以取得与UDCA联用相似的效果,而联合
UDCA可以更有效降低甘胆酸和胆汁酸水平。

%Objective To observe the clinical effects and the safety of S-adenosy-L-methionine ( SAMe ) associated with ursodeoxycholic acid (UDCA) in treating intrahepatic cholestasis of pregnancy (ICP). Methods Eighty patients with ICP were randomly divided into treatment group ( treated with UDCA orally, 250 mg, TID and simultaneously with intravenous SAMe 1. 0 g, qd) and control group (treated with intravenous SAMe 1. 0 g, qd). Pruritus degree, serum total bilirubin (TB), total bile acid (TBA), glycocholic acid (CG), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were analyzed before and after the treatment, and the pregnancy outcomes, such as the rate of premature, uterine-incision delivery and fetal distress were recorded. Results After treatment, the pruritus degree and the levels of TB, TBA, CG, ALT AST were decreased significantly compared with pretreatment in both groups. TB, TBA, AST and ALT of the treatment group decreased from (27.83±9. 34), (45. 62±18. 30) μmol·L-1, (195. 98±30. 22), (188. 69±29. 11) U·L-1 to (11. 81±4. 91), (11. 88±2. 23) μmol·L-1, (73.
59±21. 53), (67. 94±30. 53) U·L-1, respectively, and TB, TBA, AST, ALT of the control group decrea sed from (27. 49±7. 87), (49. 12±10. 39) μmol·L-1, (211. 93±34. 9), (210. 40±43. 39) U·L-1 to (16. 08± 6.23), (23.88±6.63)
μmol·L-1, (87. 20±32. 52), (81. 77±35. 16) U·L-1, respectively (P<0. 05). Compared with control group, improvements of liver function, the rates of premature delivery, fetal distress and uterine-incision delivery were not significantly different in the treatment group (P>0. 05), but the declines of TB, TBA and CG in treatment group were superior to those of the control
group (P<0. 05). Conclusion In terms of improving pruritus, liver function and pregnancy outcome, single SAMe application could obtain similar effects compared with SAMe combined with UDCA, but SAMe combined with UDCA is more effective than the single SAMe application in decreasing the level of TBA and CG.
【总页数】4页(P1040-1043)
【作者】朱瑜;黄小萍;谢涵
【作者单位】同济大学附属上海市第一妇婴保健院1.药剂科临床药学室;同济大学附属上海市第一妇婴保健院1.药剂科临床药学室;产科，上海 200040
【正文语种】中文
【中图分类】R975.5;R714.7
【相关文献】
1.熊去氧胆酸胶囊联合注射用丁二磺酸腺苷蛋氨酸治疗78例重度妊娠期肝内胆汁淤积症的疗效 [J], 齐晓伟;李红生
2.熊去氧胆酸联合低分子肝素钙与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的临床疗效 [J], 孟庆宏
3.熊去氧胆酸联合低分子肝素钙与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的临床疗效 [J], 孟庆宏
4.熊去氧胆酸、丁二磺酸腺苷蛋氨酸联合多烯磷脂酰胆碱治疗妊娠期肝内胆汁淤积症效果 [J], 姚岳红;何雪莲
5.熊去氧胆酸联合丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症患者肝功能及胎儿窘迫发生情况分析 [J], 熊建芳
因版权原因，仅展示原文概要，查看原文内容请购买。